Latest Updates

The board of directors of Abbott has declared a quarterly common dividend of 24 cents per share. This marks the 365th consecutive…

Asia Pacific to show fast growth rates in the next five years

Commences third batch of Master of Public Health (MPH)

Forays into the Rs 800-crore nasal inhaler segment

Net sales of the pharmaceuticals business grew by 1.2 per cent during the quarter ended December 31, 2014

Celon will supply the product to Lupin for its commercialisation in the US, Canada, Mexico, and other key markets

EBITDA grew by 95 per cent

Consolidated net profit was at Rs 1,147.60 million

The multiple dosing studies are expected to be completed by Q2 2015

In Q3FY15, the net sales / income from operations was at Rs 4,280 crores

Partnership will help its customers respond to the growing needs of the pharmaceutical industry for safe and cost-effective…

The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being developed as…

Sees 14 per cent increase in revenue for the nine months ended December 31, 2014

Aim to spur sluggish growth of biotech sector

To manufacture stem cell-based treatment of complex perianal fistulas in crohn’s disease

The anti-retrovirals drugs will be manufactured in Cipla’s state-of-the-art manufacturing facilities in India, which has been…

Patients, investigators to be speakers at Annual ISCR Conference

It ensures easy use and correct positioning of eye droppers

They are designed for sensitive and high-value injectables

The visit aimed to understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality…